National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
Adult Brain Tumors Treatment (PDQ®)     
Last Modified: 01/02/2009
Health Professional Version
Germ Cell Tumors

Current Clinical Trials

The prognosis and treatment of patients with germ cell tumors—which include germinoma, embryonal carcinoma, choriocarcinoma, and teratoma—depend on tumor histology, tumor location, presence and amount of biological markers, and surgical resectability.[1,2] (Refer to the Germ Cell Tumors 1 section in the Classification 2 section of this summary for more information.)

Current Clinical Trials

Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with adult central nervous system germ cell tumor 3. The list of clinical trials can be further narrowed by location, drug, intervention, and other criteria.

General information about clinical trials is also available from the NCI Web site 4.

References

  1. Edwards MS, Hudgins RJ, Wilson CB, et al.: Pineal region tumors in children. J Neurosurg 68 (5): 689-97, 1988.  [PUBMED Abstract]

  2. Linstadt D, Wara WM, Edwards MS, et al.: Radiotherapy of primary intracranial germinomas: the case against routine craniospinal irradiation. Int J Radiat Oncol Biol Phys 15 (2): 291-7, 1988.  [PUBMED Abstract]



Table of Links

1http://www.cancer.gov/cancertopics/pdq/treatment/adultbrain/HealthProfessional/
342.cdr#Section_342
2http://www.cancer.gov/cancertopics/pdq/treatment/adultbrain/HealthProfessional/
5.cdr#Section_5
3http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?diagnosis=41197&tt=1&a
mp;format=2&cn=1
4http://www.cancer.gov/clinicaltrials